Vaxart
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Vaxart and buy or sell other stocks, ETFs, and their options commission-free!About VXRT
Vaxart, Inc. is a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV).
CEOSteven Lo
CEOSteven Lo
Employees115
Employees115
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2004
Founded2004
Employees115
Employees115
VXRT Key Statistics
Market cap90.06M
Market cap90.06M
Price-Earnings ratio-1.64
Price-Earnings ratio-1.64
Dividend yield—
Dividend yield—
Average volume484.12K
Average volume484.12K
High today$0.375
High today$0.375
Low today$0.3413
Low today$0.3413
Open price$0.3601
Open price$0.3601
Volume343.25K
Volume343.25K
52 Week high$0.98
52 Week high$0.98
52 Week low$0.2606
52 Week low$0.2606
Stock Snapshot
The current Vaxart(VXRT) stock price is $0.37, with a market capitalization of 90.06M. The stock trades at a price-to-earnings (P/E) ratio of -1.64.
During the trading session on 2025-12-12, Vaxart(VXRT) shares reached a daily high of $0.38 and a low of $0.34. At a current price of $0.37, the stock is +8.4% higher than the low and still -1.3% under the high.
Trading volume for Vaxart(VXRT) stock has reached 343.25K, versus its average volume of 484.12K.
The stock's 52-week range extends from a low of $0.26 to a high of $0.98.
The stock's 52-week range extends from a low of $0.26 to a high of $0.98.
People also own
Based on the portfolios of people who own VXRT. This list is generated using Robinhood data, and it’s not a recommendation.